NeuroBo Pharmaceuticals, Inc.
(NASDAQ : NRBO)

( )
NRBO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
IMMUImmunomedics, Inc. -0.26%85.0311.0%$728.04m
MRNAModerna, Inc. 0.33%70.750.0%$670.05m
AMGNAmgen, Inc. 2.36%254.161.3%$669.90m
ILMNIllumina, Inc. 1.17%309.083.5%$646.09m
NVAXNovavax, Inc. 0.37%108.3596.5%$600.09m
GILDGilead Sciences, Inc. 1.76%63.191.0%$591.39m
REGNRegeneron Pharmaceuticals, Inc. -2.41%559.782.7%$463.31m
VRTXVertex Pharmaceuticals, Inc. 0.67%272.121.9%$349.26m
BIIBBiogen, Inc. 0.47%283.681.6%$346.64m
SRNESorrento Therapeutics, Inc. -3.88%11.151.4%$316.35m
EXASEXACT Sciences Corp. -0.06%101.9520.7%$266.37m
ALXNAlexion Pharmaceuticals, Inc. 1.75%114.432.0%$262.90m
SGENSeattle Genetics, Inc. 2.48%195.696.0%$235.67m
VXRTVaxart, Inc. -2.56%6.650.0%$191.96m
MNTAMomenta Pharmaceuticals, Inc. -0.02%52.483.0%$191.71m

Company Profile

NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA.